IMMUNIC, INC. Files S-8 for Employee Stock Plans
Ticker: IMUX · Form: S-8 · Filed: 2026-04-09T16:30:55-04:00
Sentiment: neutral
Topics: employee-benefit-plan, stock-registration, sec-filing
TL;DR
IMMUNIC just filed an S-8, meaning they're ready to give out stock to employees.
AI Summary
On April 9, 2026, IMMUNIC, INC. filed an S-8 form with the SEC, registering an unspecified number of securities to be offered under its employee benefit plans. This filing indicates the company is making shares available for its employees, likely as part of compensation or incentive programs. The filing does not specify a dollar amount for the offering.
Why It Matters
This filing allows IMMUNIC, INC. to issue stock to employees, which can be a key tool for attracting and retaining talent, and aligning employee interests with shareholder value.
Risk Assessment
Risk Level: low — An S-8 filing is a routine registration of securities for employee benefit plans and does not inherently represent a new financial risk or opportunity.
Key Players & Entities
- IMMUNIC, INC. (company) — Filer of the S-8 registration statement
- 0001280776 (company) — CIK number for IMMUNIC, INC.
- 2026-04-09 (date) — Filing date and effectiveness date of the S-8
FAQ
What type of securities are being registered?
The filing is an S-8, which registers securities to be offered to employees in connection with employee benefit plans. The specific type of security (e.g., common stock) is not detailed in the provided summary information.
How many shares are being registered?
The provided filing details do not specify the exact number of shares being registered under the S-8 form.
What is the purpose of this S-8 filing?
The purpose is to register securities for IMMUNIC, INC.'s employee benefit plans, allowing the company to issue these securities to employees.
When was this filing accepted by the SEC?
The filing was accepted on April 9, 2026.
What is IMMUNIC, INC.'s business?
IMMUNIC, INC. is in the Pharmaceutical Preparations industry, classified under SIC code 2834.
From the Filing
EDGAR Filing Documents for 0001193805-26-000426 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form S-8 - Securities to be offered to employees in employee benefit plans: SEC Accession No. 0001193805-26-000426 Filing Date 2026-04-09 Accepted 2026-04-09 16:30:55 Documents 15 Effectiveness Date 2026-04-09 Interactive Data Document Format Files Seq Description Document Type Size 1 e665230_s8-immunic.htm S-8 62593 2 e665230_ex5-1.htm EX-5.1 10333 3 e665230_ex23-1.htm EX-23.1 1766 4 e665230_ex99-1.htm EX-99.1 218301 5 FILING FEE IXBRL e665230_ex107.htm iXBRL EX-FILING FEES 12922 6 GRAPHIC image1.jpg GRAPHIC 8861 Complete submission text file 0001193805-26-000426.txt 438674 Data Files Seq Description Document Type Size 18 EXTRACTED XBRL INSTANCE DOCUMENT e665230_ex107_htm.xml XML 4856 Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818 IMMUNIC, INC. (Filer) CIK : 0001280776 (see all company filings) EIN. : 562358443 | State of Incorp.: DE | Fiscal Year End: 1231 Type: S-8 | Act: 33 | File No.: 333-294952 | Film No.: 26852019 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)